Issues
-
Cover Image
Cover Image
Multiple FGFR2 kinase domain mutations identified in melanoma tumors and cell lines mapped onto the crystal structure of the unphosphorylated wild type FGFR2 kinase domain (PDB ID: 2PSQ) suggest that these mutations should impair the kinase activity of FGFR2. The N-terminal lobe of kinase domain is colored in light blue, the C-terminal lobe in bright blue, the activation loop in magenta, the kinase hinge region in green and the N-terminal tail of the kinase domain in wheat. For details see article by Gartside and colleagues on page 41. - PDF Icon PDF LinkTable of Contents
Molecular Cancer Research
Table of Contents
Subject Review
Angiogenesis, Metastasis, and the Cellular Microenvironment
Cancer Genes and Genomics
Loss-of-Function Fibroblast Growth Factor Receptor-2 Mutations in Melanoma
Cell Cycle, Cell Death, and Senescence
DNA Damage and Cellular Stress Responses
Signaling and Regulation
Journal Archive
Molecular Cancer Research
(2002-Present; volumes 1-current)Published monthly since November, 2002.
(ISSN 0008-5472)
Cell Growth & Differentiation
(1990-2002; volumes 1-13)Published monthly 1990- September, 2002.
(ISSN 1044-9523)
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.